Castle Biosciences (CSTL) Preferred Stock Liabilities (2018 - 2019)
Castle Biosciences (CSTL) posted Preferred Stock Liabilities of $45.1 million for Q2 2019, little changed sequentially from $45.1 million in Q1 2019, and up 0.51% YoY from $44.9 million in Q2 2018.
Castle Biosciences (CSTL) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends
Castle Biosciences has reported Preferred Stock Liabilities for 2 years, with the latest figure at $45.1 million in Q2 2019.
- Quarterly Preferred Stock Liabilities rose 0.51% year-over-year to $45.1 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $45.1 million (up 0.51% YoY) and the FY2018 annual result came in at $45.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities was little changed at $45.1 million in Q2 2019 per CSTL's latest filing, from $45.1 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $45.1 million in Q2 2019 and troughed at $44.9 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Castle Biosciences | 1.04 Bn | 773.13 Mn | 79.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 45.11 Mn |
| Mar 31, 2019 | 45.05 Mn |
| Dec 31, 2018 | 45.00 Mn |
| Sep 30, 2018 | 44.94 Mn |
| Jun 30, 2018 | 44.88 Mn |